SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech, Indications

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (1)7/8/1999 3:32:00 PM
From: LLCF  Read Replies (5) of 22
 
PSORIASIS-

So here is the start of the Psoriasis "rolling commentary" provided to you by Pseudo
Biologist on the XOMA thread:

Indication: Psoriasis
Market: Small, Moderate, Giant
Approved competition: Weak, Moderate, Strong

Clinical [pre-clinic?] competition:

Ligands's *retins, and Ontak, Ph?
Abgenix anti-IL8 human antibody Ph?
ICOS's anti-ICAM-3 antibody
Vertex small molecule inhibitor of T-cell proliferation
Axys tryptase small molecule inhibitor
IDEC's anti-B7 and (maybe??) anti-CD4 antibodies ...
Biogen's Amevive, phIIb
Xoma Hu1124, Anti-CD11a antibody, Ph11
ISIS 2302 (ICAM-1 inhibitor)

Worthwhile links:

Message 10418030
recap.com

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext